Trials / Completed
CompletedNCT00919490
A Study of Single Dose of ABT-333 in Healthy Male Adults
A Double-blind, Randomized, Placebo-controlled Phase 1 Study in Healthy Male Adults to Evaluate the Safety, Tolerability and Pharmacokinetic Profiles of Single Dose of ABT-333
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Abbott · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The objectives of this study is to assess the safety, tolerability, and pharmacokinetics of blind, escalating, single, oral doses of ABT-333 under nonfasting conditions in healthy male adult in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-333 | Tablet, see arms for interventional description |
| DRUG | Placebo | Tablet, see arms for interventional description. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-08-01
- First posted
- 2009-06-12
- Last updated
- 2010-10-25
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00919490. Inclusion in this directory is not an endorsement.